Does APREMILAST Cause Interstitial lung disease? 43 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 43 reports of Interstitial lung disease have been filed in association with APREMILAST (Otezla). This represents 0.0% of all adverse event reports for APREMILAST.
43
Reports of Interstitial lung disease with APREMILAST
0.0%
of all APREMILAST reports
6
Deaths
25
Hospitalizations
How Dangerous Is Interstitial lung disease From APREMILAST?
Of the 43 reports, 6 (14.0%) resulted in death, 25 (58.1%) required hospitalization, and 8 (18.6%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APREMILAST. However, 43 reports have been filed with the FAERS database.
What Other Side Effects Does APREMILAST Cause?
Diarrhoea (23,752)
Nausea (21,352)
Psoriasis (19,255)
Headache (17,024)
Drug ineffective (14,121)
Abdominal discomfort (7,653)
Psoriatic arthropathy (7,035)
Vomiting (5,959)
Rash (5,883)
Pain (5,676)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which APREMILAST Alternatives Have Lower Interstitial lung disease Risk?
APREMILAST vs APREPITANT
APREMILAST vs APROTININ
APREMILAST vs ARANESP
APREMILAST vs ARAVA
APREMILAST vs AREDIA